Page last updated: 2024-10-20

pteridines and Cholangiocarcinoma

pteridines has been researched along with Cholangiocarcinoma in 3 studies

Cholangiocarcinoma: A malignant tumor arising from the epithelium of the BILE DUCTS.

Research Excerpts

ExcerptRelevanceReference
"As most cholangiocarcinomas are chemotherapy-resistant due to mechanisms preventing tumor cell death, we investigated the effect of Cisplatin on cholangiocellular carcinoma (CCA) cell lines KMCH-1 and Mz-Ch-1."1.46Bcl-2 degradation is an additional pro-apoptotic effect of polo-like kinase inhibition in cholangiocarcinoma cells. ( Canbay, A; Fingas, CD; Gerken, G; Jafoui, S; Mertens, JC; Paul, A; Swoboda, S; Sydor, S; Wingerter, L, 2017)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sydor, S2
Jafoui, S1
Wingerter, L1
Swoboda, S1
Mertens, JC2
Gerken, G1
Canbay, A2
Paul, A2
Fingas, CD2
Razumilava, N1
Bronk, SF1
Christensen, JD1
Rizvi, SH1
Treckmann, JW1
Sirica, AE1
Gores, GJ1
Thrum, S1
Lorenz, J1
Mössner, J1
Wiedmann, M1

Other Studies

3 other studies available for pteridines and Cholangiocarcinoma

ArticleYear
Bcl-2 degradation is an additional pro-apoptotic effect of polo-like kinase inhibition in cholangiocarcinoma cells.
    World journal of gastroenterology, 2017, Jun-14, Volume: 23, Issue:22

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bile Duct Neoplasms; Cell Cycle Proteins;

2017
Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma.
    Hepatology (Baltimore, Md.), 2013, Volume: 58, Issue:4

    Topics: Animals; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Survival;

2013
Polo-like kinase 1 inhibition as a new therapeutic modality in therapy of cholangiocarcinoma.
    Anticancer research, 2011, Volume: 31, Issue:10

    Topics: Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Deoxycyti

2011